Nükleer Tıpta PET/MR Uygulamaları
Özet
Referanslar
Ankara Universitesi Tip Fakultesi, Radyoloji Anabilim Dali, Ankara, Turkiye, Erden I. PET/MR. Trd Sem. 2020 Oct 13;8(2):285–93.
Demir M. PET/MRI Systems: What is the Difference from PET/CT? nts. 2024 Dec 16;10(3):206–12.
Camoni L, Mansi L, editors. Nuclear Medicine Hybrid Imaging for Radiographers Technologists [Internet]. Cham: Springer Nature Switzerland; 2025. Available from: https://link.springer.com/10.1007/978-3-031-86228-1
Sönmezoğlu K, Şahin OE. Basic Principles in PET/MRI Evaluation. nts. 2024 Dec 16;10(3):213–32.
Semmler W, Schwaiger M. Molecular imaging. Berlin: Springer-Verlag; 2008. (Handbook of experimental pharmacology).
Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Antoch G, Ingenwerth M, et al. Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding. Cancers. 2021 Jun 11;13(12):2928.
Hu Z, Yang W, Liu H, Wang K, Bao C, Song T, et al. From PET/CT to PET/MRI: Advances in Instrumentation and Clinical Applications. Mol Pharmaceutics. 2014 Nov 3;11(11):3798–809.
Rausch I, Quick HH, Cal-Gonzalez J, Sattler B, Boellaard R, Beyer T. Technical and instrumentational foundations of PET/MRI. European Journal of Radiology. 2017 Sep;94:A3–13.
Şahin OE. Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI): Common Pitfalls and Limitations in Clinical Practice. nts. 2024 Dec 16;10(3):249–56.
Asa S. Principal MRI Sequences Applied in PET/MRI Oncologic Imaging. nts. 2024 Dec 16;10(3):233–40.
Nevo E, Kamvosoulis P, Currie G. PET/MRI, Part 3: Protocols and Procedures. J Nucl Med Technol. 2022 Mar;50(1):17–24.
Toplutaş KN, Uslu Beşli RL. Use of Contrast Agents in Positron Emission Tomography/Magnetic Resonance Imaging. nts. 2024 Dec 16;10(3):241–8.
Dursun E, Özkan E. PET/MR Imagıng in Head and Neck Cancers. nts. 2024 Dec 16;10(3):274–83.
Sağer SM, Şahin K. PET/MRI in Colorectal Cancers. nts. 2024 Dec 16;10(3):322–8.
Soydal Ç, İnal G, Küçük Ö. PET/MR Imaging in Gynecological Malignancies. nts. 2024 Dec 16;10(3):344–52.
Araz M. PET/MR in Breast Cancers. nts. 2024 Dec 16;10(3):284–92.
Aydos U, Erbil Çapçı EN. Positron Emission Tomography/Magnetic Resonance Imaging in Thoracic Tumors. nts. 2024 Dec 16;10(3):293–312.
Küçük NÖ, İnal G, Soydal Ç. PET/MR Imaging in Liver Tumors. nts. 2024 Dec 16;10(3):313–21.
Ehman EC, Johnson GB, Villanueva‐Meyer JE, Cha S, Leynes AP, Larson PEZ, et al. PET/MRI: Where might it replace PET/CT? Magnetic Resonance Imaging. 2017 Nov;46(5):1247–62.
Evangelista L, Zattoni F, Cassarino G, Artioli P, Cecchin D, Dal Moro F, et al. PET/MRI in prostate cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):859–73.
Gammel MCM, Solari EL, Eiber M, Rauscher I, Nekolla SG. A Clinical Role of PET-MRI in Prostate Cancer? Seminars in Nuclear Medicine. 2024 Jan;54(1):132–40.
Li M, Huang Z, Yu H, Wang Y, Zhang Y, Song B. Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis. European Journal of Radiology. 2019 Apr;113:225–31.
Şahin OE. Positron Emission Tomography/Magnetic Resonance Imaging in Hematologic Malignancies. nts. 2024 Dec 16;10(3):353–62.
Ateş SG, Akdemir ÜÖ. PET/MR Imaging in Neurooncology. nts. 2024 Dec 16;10(3):257–73.
Currie GM, Leon J, Nevo E, Kamvosoulis P. PET/MRI, Part 4: Clinical Applications. J Nucl Med Technol. 2022 Jun;50(2):90–6.
Sun J, Cong C, Li X, Zhou W, Xia R, Liu H, et al. Identification of Parkinson’s disease and multiple system atrophy using multimodal PET/MRI radiomics. Eur Radiol. 2023 Aug 3;34(1):662–72.
Kazimierczyk R, Kaminski KA, Nekolla SG. Cardiac PET/MRI: Recent Developments and Future Aspects. Seminars in Nuclear Medicine. 2024 Sep;54(5):733–46.
Aizaz M, Moonen RPM, Van Der Pol JAJ, Prieto C, Botnar RM, Kooi ME. PET/MRI of atherosclerosis. Cardiovasc Diagn Ther. 2020 Aug;10(4):1120–39.
Whittington B, Dweck MR, Van Beek EJR, Newby D, Williams MC. PET‐MRI of Coronary Artery Disease. Magnetic Resonance Imaging. 2023 May;57(5):1301–11.
Kogan F, Broski SM, Yoon D, Gold GE. Applications of PET‐MRI in musculoskeletal disease. Magnetic Resonance Imaging. 2018 Jul;48(1):27–47.
Guja KE, Behr G, Bedmutha A, Kuhn M, Nadel HR, Pandit-Taskar N. Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases. Seminars in Nuclear Medicine. 2024 May;54(3):438–55.
Telli T, Desaulniers M, Pyka T, Caobelli F, Forstmann S, Umutlu L, et al. What Role Does PET/MRI Play in Musculoskeletal Disorders? Seminars in Nuclear Medicine. 2025 Mar;55(2):277–89.
Ateş SG, Atay LÖ. PET/MR Imaging in Pediatric Oncology. nts. 2024 Dec 16;10(3):369–82.
Romeo V, Kapetas P, Clauser P, Baltzer PAT, Rasul S, Gibbs P, et al. A Simultaneous Multiparametric 18F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer. Cancers. 2022 Aug 16;14(16):3944.
İndir
Yayınlanan
Lisans
LisansBu İnternet Sitesi içeriğinde yer alan tüm eserler (yazı, resim, görüntü, fotoğraf, video, müzik vb.) Akademisyen Kitabevine ait olup, 5846 sayılı Fikir ve Sanat Eserleri Kanunu ve 5237 sayılı Türk Ceca Kanunu kapsamında korunmaktadır. Bu hakları ihlal eden kişiler, 5846 sayılı Fikir ve Sanat eserleri Kanunu ve 5237 sayılı Türk Ceza Kanununda yer alan hukuki ve cezai yaptırımlara tabi olurlar. Yayınevi ilgili yasal yollara başvurma hakkına sahiptir.